Abbott Labs (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Moody's•5 days ago
New York, February 23, 2017-- Moody's Investors Service assigned a Baa3 rating to Abbott Laboratories' proposed new senior unsecured note offering. The rating outlook is stable. There are no changes to ...
- TheStreet.com•5 days ago
Abbott Labs completed the acquisition of St. Jude Medical in January.
ABT : Summary for Abbott Laboratories - Yahoo Finance
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||44.01 x 100|
|Ask||45.80 x 100|
|Day's Range||45.19 - 45.56|
|52 Week Range||36.76 - 45.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||48.52|
|Dividend & Yield||1.06 (2.32%)|
|1y Target Est||N/A|